Changchun BCHT Biotechnology Co. (SHA:688276)

SHA:688276 Revenue

Changchun BCHT Biotechnology Co. had revenue of 147.35M CNY in the quarter ending March 31, 2026, a decrease of -9.21%. This brings the company's revenue in the last twelve months to 590.13M, down -47.36% year-over-year. In the year 2025, Changchun BCHT Biotechnology Co. had annual revenue of 605.07M, down -50.77%.

• Revenue (ttm): 590.13M
• Revenue Growth: -47.36%
• P/S Ratio: 10.40
• Revenue / Employee: 471.35K
• Employees: 1,252
• Market Cap: 6.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	605.07M	-624.01M	-50.77%
Dec 31, 2024	1.23B	-595.60M	-32.64%
Dec 31, 2023	1.82B	753.24M	70.30%
Dec 31, 2022	1.07B	-130.58M	-10.86%
Dec 31, 2021	1.20B	-239.33M	-16.60%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 3, 2026

Data Sources Report a data error